Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | USP14 | P54578 | 1/20 | 0.49 |
| ▸ | USP7 | Q93009 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clopirac SCHEMBL28121041 | 0.90 | NOTUM (0.51) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL12608916 | 0.88 | NOTUM (0.57) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL11377279 | 0.87 | NOTUM (0.56) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| Delmetacin SCHEMBL9446710 | 0.80 | ABCB1 (0.73) | MAPTNPSR1PTGS2 | |
| SCHEMBL16752445 | 0.80 | NOTUM (0.49) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL11257155 | 0.77 | POLB (0.51) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL1980763 | 0.76 | NOTUM (1.00) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL12608917 | 0.76 | SHMT2 (0.46) | NOTUMALDH1A1MAPK1SMN1; SMN2POLB | |
| SCHEMBL19298013 | 0.74 | NOTUM (0.48) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 | |
| SCHEMBL13739403 | 0.74 | ALDH1A1 (1.00) | NOTUMALDH1A1MAPK1NR1H4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5908 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| US-RE50218-E1 | Non-steroidal anti-inflammatory ophthalmic compositions | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-11-26 | — | — | US | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| WO-2023142996-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | 上海岸阔医药科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| EP-4034087-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS Research Inc. (CA) | 2022-08-03 | — | — | EP | claimed |
| US-20220218611-A1 | LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS | DDS RESEARCH INC. (CA) | 2022-07-14 | — | — | US | claimed |
| EP-3998932-A1 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | Parsons, C. Lowell (US) | 2022-05-25 | — | — | EP | claimed |
| US-20220110979-A1 | FIBROBLAST REGENERATIVE CELLS | FIGENE, LLC | 2022-04-14 | — | — | US | claimed |
| US-5330981-A | Antiinflammatory agents | ISTITUTO GENTILI S.P.A. (IT) | 1994-07-19 | — | — | US | claimed |
| EP-0569411-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES. | GENTILI IST SPA (IT) | 1993-11-18 | — | — | EP | claimed |
| EP-0537313-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY. | GENTILI IST SPA (IT) | 1993-04-21 | — | — | EP | claimed |
| WO-1992019584-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY | ISTITUTO GENTILI S.P.A. (IT) | 1992-11-12 | — | — | WO | claimed |
| WO-1992013864-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES | ISTITUTO GENTILI S.P.A. (IT) | 1992-08-20 | — | — | WO | claimed |
| EP-0452908-A2 | Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids | ABBOTT LABORATORIES (US) | 1991-10-23 | — | — | EP | claimed |
| US-5032588-A | Non-steroidal antiinflammatory | ABBOTT LABORATORIES (US) | 1991-07-16 | — | — | US | claimed |
| WO-1991008744-A1 | THIAZOLE LIPOXYGENASE-INHIBITING COMPOUNDS DERIVED FROM NON-STEROIDAL ANTIINFLAMMATORY CARBOXYLIC ACIDS | ABBOTT LABORATORIES (US) | 1991-06-27 | — | — | WO | claimed |
| EP-0408496-A2 | Solid dosage form for pharmaceutical substances | CIBA-GEIGY AG (CH) | 1991-01-16 | — | — | EP | claimed |
| EP-0374602-A1 | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-06-27 | — | — | EP | claimed |